Peter K. Plinkert

6.6k total citations · 1 hit paper
181 papers, 4.7k citations indexed

About

Peter K. Plinkert is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Peter K. Plinkert has authored 181 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 63 papers in Otorhinolaryngology and 39 papers in Oncology. Recurrent topics in Peter K. Plinkert's work include Head and Neck Cancer Studies (39 papers), Hearing, Cochlea, Tinnitus, Genetics (29 papers) and Hearing Loss and Rehabilitation (24 papers). Peter K. Plinkert is often cited by papers focused on Head and Neck Cancer Studies (39 papers), Hearing, Cochlea, Tinnitus, Genetics (29 papers) and Hearing Loss and Rehabilitation (24 papers). Peter K. Plinkert collaborates with scholars based in Germany, United States and Italy. Peter K. Plinkert's co-authors include Ingo Baumann, Mark Praetorius, Jürgen Debus, Sebastian Adeberg, Serkan Sertel, Hendrik Rathke, Paul Flechsig, Uwe Haberkorn, Clemens Kratochwil and Frederik L. Giesel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Peter K. Plinkert

173 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

2019 964 citations Sebastian Adeberg, Peter K. Plinkert et al. profile →

Peers

Countries citing papers authored by Peter K. Plinkert

Since Specialization

Citations

This map shows the geographic impact of Peter K. Plinkert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Plinkert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Plinkert more than expected).

Fields of papers citing papers by Peter K. Plinkert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Plinkert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Plinkert. The network helps show where Peter K. Plinkert may publish in the future.

Co-authorship network of co-authors of Peter K. Plinkert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Plinkert. A scholar is included among the top collaborators of Peter K. Plinkert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Plinkert. Peter K. Plinkert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy 2024 ·Technology in Cancer Research & Treatment ·Kristin Lang, Thomas Held, Christian Freudlsperger, (unknown), Jürgen Hoffmann, Peter K. Plinkert, Jürgen Debus, Sebastian Adeberg	0
2	Impact of Psychiatric Symptoms on Nasal Perception in Septorhinoplasty Patients 2024 ·Facial Plastic Surgery ·(unknown), Ingo Baumann, Frank Riedel, Peter K. Plinkert, Olcay Cem Bulut	1
3	Recurrent laryngeal lymphangiomatosis in a patient with Proteus syndrome: A case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Peter K. Plinkert, (unknown)	2
4	Establishment of a Machine Learning Model for the Risk Assessment of Perineural Invasion in Head and Neck Squamous Cell Carcinoma 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Fabian Stögbauer, Bohai Feng, (unknown), Sebastian F. N. Bode, Peter K. Plinkert, (unknown), Jochen Heß	12
5	Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma 2022 ·Cancers ·Gerhard Dyckhoff, Christel Herold‐Mende, Sabine Scherer, Peter K. Plinkert, Rolf Warta	6
6	Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy 2022 ·Cancers ·(unknown), Rami A. El Shafie, Sebastian Adeberg, Klaus Herfarth, Laila König, Kristin Lang, Juliane Hörner‐Rieber, Peter K. Plinkert, Wolfgang Wick, Felix Sahm, (unknown), Jürgen Debus, Denise Bernhardt	5
7	Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps? 2022 ·Annals of Allergy Asthma & Immunology ·(unknown), Lara Derycke, (unknown), (unknown), Tim Delemarre, Carlo Cavaliere, Peter K. Plinkert, Gabriële Holtappels, Claus Bachert	4
8	An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment 2021 ·Cancers ·Gerhard Dyckhoff, Rolf Warta, Christel Herold‐Mende, (unknown), Peter K. Plinkert, Heribert Ramroth	9
9	Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients 2021 ·Cancers ·Gerhard Dyckhoff, Rolf Warta, Christel Herold‐Mende, (unknown), Peter K. Plinkert, Heribert Ramroth	3
10	Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma 2021 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), Ina Kurth, Dana Holzinger, Christa Flechtenmacher, Peter K. Plinkert, Karim Zaoui, Jochen Heß	6
11	Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial 2020 ·Radiation Oncology ·Thomas Held, Kristin Lang, Sebastian Regnery, (unknown), (unknown), (unknown), Eric Tonndorf‐Martini, Johannes Krisam, Peter K. Plinkert, Karim Zaoui, Christian Freudlsperger, Julius Moratin, Jürgen Krauß, Semi Harrabi, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	10
12	<p>Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy</p> 2020 ·Cancer Management and Research ·Kristin Lang, Rami A. El Shafie, Sati Akbaba, Ronald Koschny, Nina Bougatf, Denise Bernhardt, Stefan Welte, Sebastian Adeberg, Matthias Häfner, Steffen Kargus, Peter K. Plinkert, Jürgen Debus, Stefan Rieken	12
13	Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control 2019 ·Cancers ·Sati Akbaba, Thomas Held, Kristin Lang, Tobias Förster, P. Federspil, Klaus Herfarth, Matthias Häfner, Peter K. Plinkert, Stefan Rieken, Jürgen Debus, Sebastian Adeberg	15
14	The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience 2019 ·Oral Oncology ·Sati Akbaba, (unknown), Andreas Möck, Thomas Held, Kristin Lang, (unknown), Tobias Förster, Sonja Katayama, Steffen Kargus, Stefan Rieken, Peter K. Plinkert, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	8
15	Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions 2019 ·Radiation Oncology ·Thomas Held, Paul Windisch, Sati Akbaba, Kristin Lang, (unknown), Jakob Liermann, Denise Bernhardt, Peter K. Plinkert, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	5
16	Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience 2019 ·Cancers ·Sati Akbaba, (unknown), Andreas Möck, Thomas Held, (unknown), Kristin Lang, Mustafa Syed, (unknown), Tobias Förster, P. Federspil, Klaus Herfarth, Peter K. Plinkert, Jürgen Debus, Sebastian Adeberg	21
17	Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer 2019 ·Cancers ·Thomas Held, Sati Akbaba, Kristin Lang, Semi Harrabi, Denise Bernhardt, Christian Freudlsperger, Steffen Kargus, Peter K. Plinkert, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	7
18	Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity 2018 ·Cancers ·Kristin Lang, (unknown), Sati Akbaba, Thomas Held, Steffen Kargus, Nina Bougatf, Denise Bernhardt, Kolja Freier, Peter K. Plinkert, Stefan Rieken, Jürgen Debus, Sebastian Adeberg	15
19	Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety 2018 ·Cancers ·Sati Akbaba, Kristin Lang, Thomas Held, Olcay Cem Bulut, (unknown), Matthias Uhl, Alexandra D Jensen, Peter K. Plinkert, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	9
20	Evaluation of Quality of Life in Patients Treated with Traditional Chinese Medicine 2010 ·Serkan Sertel, Henry Johannes Greten, (unknown), Thomas Efferth, Peter K. Plinkert, Ingo Baumann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact